Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
5 On Your Side: How to check your credit score is accurate
Recommended
How marijuana reclassification could affect North Carolinians
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pulse Biosciences CS
(NQ:
PLSE
)
8.050
+0.450 (+5.92%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pulse Biosciences CS
< Previous
1
2
3
4
Next >
Pulse Biosciences Schedules Fourth Quarter & Full Year 2022 Financial Results Conference Call for March 30, 2023
March 02, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Its Novel Nanosecond Pulsed Field Ablation System Will Be Highlighted at the 2023 AF Symposium
February 02, 2023
From
Pulse Biosciences
Via
Business Wire
Pulse Biosciences Reports Third Quarter 2022 Financial Results
November 10, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules Third Quarter 2022 Financial Results Conference Call for November 10, 2022
October 27, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Positive Clinical Data on Nano-Pulse Stimulation Procedure for Low-Risk Basal Cell Carcinoma Lesions
October 06, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia
September 26, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
September 20, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Reports Second Quarter 2022 Financial Results
August 10, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Receives FDA 510(k) Clearance of Expanded Energy Settings for use with the CellFX® System
August 04, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules Second Quarter 2022 Financial Results Conference Call for August 10, 2022
July 27, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 16, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Announces the Closing of Its Rights Offering
June 09, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. (NASDAQ:PLSE) Long Term Investor Alert: Investigation of Potential Wrongdoing
June 03, 2022
San Diego, CA -- (SBWIRE) -- 06/03/2022 -- Certain directors of Pulse Biosciences, Inc. are under investigation concerning potential breaches of fiduciary duties.
Via
SBWire
Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering
June 03, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm
May 23, 2022
From
The Schall Law Firm
Via
Business Wire
Pulse Biosciences, Inc. Announces Changes to its Rights Offering
May 19, 2022
From
Pulse Biosciences
Via
Business Wire
Pulse Biosciences Reports First Quarter 2022 Financial Results
May 11, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Announces Commencement of Rights Offering
May 04, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules First Quarter 2022 Financial Results Conference Call for May 11, 2022
April 28, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences to Present New Data on Nano-Pulse Stimulation Procedure for Sebaceous Hyperplasia and for Focal Epithelial Hyperplasia at 2022 American Society of Laser Medicine and Surgery Annual Conference
April 26, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
PULSE BIOSCIENCES (PLSE) SHAREHOLDER ALERT - Andrews & Springer LLC Is Investigating Pulse Biosciences, Inc. for Potential Securities Fraud Violations and Breaches of Fiduciary Duty
April 25, 2022
From
Andrews & Springer LLC
Via
Business Wire
Final Deadline Reminder: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm
April 18, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Deadline Today: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm
April 18, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
PULSE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Pulse Biosciences, Inc. and Encourages Investors to Contact the Firm
April 15, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Pulse Biosciences, Inc. (PLSE)
April 15, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Deadline Monday Notice: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm
April 15, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Pulse Biosciences, Inc. Announces Rights Offering
April 14, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Deadline Monday Reminder: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm
April 14, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Monday Deadline Notice: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm
April 13, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
PLSE FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors to Secure Counsel Before Important April 18 Deadline in Securities Class Action - PLSE
April 09, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.